Ursprung des Netzwerks ersten Grades von Wenshou Wang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology METiS Therapeutics, Inc. is a discovery technology and therapeutics company that aims to develop best-in-class drug assets across various therapeutic areas. The company is based in Cambridge, MA and has subsidiaries in the United States and China. Joining the team offers an exciting career in therapeutics for AI drug discovery. METiS Therapeutics was founded by Christopher Lai and Wenshou Wang, with Christopher Lai serving as the CEO since incorporation.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Wenshou Wang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KALA BIO, INC. | Pharmaceuticals: Major | Founder | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Metis Pharmaceuticals
 Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of METiS Therapeutics, Inc., Metis Pharmaceuticals is a Chinese company that focuses on independent innovation and research and development capabilities in the pharmaceutical industry. The company is based in Hangzhou, China. The company aims to accelerate the pace of innovation and promote high-quality industry development. Dishita Pharmaceuticals, the parent company, supports Metis Pharmaceuticals in developing more effective treatment drugs for patients. It was founded in 2019 by Christopher Lai, who has been the CEO since then. | Pharmaceuticals: Major | Founder |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
| China | 2 |
Sektoral
| Health Technology | 6 |
| Finance | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
| Producer Manufacturing | 2 |
Operativ
| Founder | 4 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hongming Chen | 8 |
| Christopher Lai | 3 |
- Börse
- Insiders
- Wenshou Wang
- Unternehmensverbindungen
